%0 Journal Article
%T Repository corticotropin injection in patients with rheumatoid arthritis resistant to biologic therapies
%A Peter A Fischer
%A Ronald J Rapoport
%J Archive of "Open Access Rheumatology : Research and Reviews".
%D 2018
%R 10.2147/OARRR.S153307
%X Although synthetic and biologic disease-modifying antirheumatic drugs are available, many patients with rheumatoid arthritis have a difficult-to-control disease and need other treatment options. Repository corticotropin injection (RCI) may alleviate symptoms and exacerbations in patients with refractory disease
%K repository corticotropin injection
%K rheumatoid arthritis
%K Disease Activity Score 28 using C-reactive protein (DAS28-CRP)
%K health-related quality of life
%K biologic failure
%K melanocortin
%K refractory rheumatoid arthritis
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5808698/